Literature DB >> 11305875

Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.

K Oyanagi1, K Tsuchiya, M Yamazaki, K Ikeda.   

Abstract

Disease-specific findings in the substantia nigra were examined in cases of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and parkinsonism-dementia complex of Guam (PDC); diseases in which the patients exhibit dementia and parkinsonism, with neurofibrillary tangles (NFTs) and glial tangles composed of hyperphosphorylated tau. Loss of pigmented neurons was extremely severe in these 3 diseases, and decrease of the nonpigmented neurons was severe in PSP and CBD. On the other hand, in PDC the decrease of the nonpigmented neurons was different in each patient. Topographically, in PSP the nonpigmented neurons were particularly depleted in the ventral part and relative preservation of the pigmented neurons was observed in the medial part at the level examined. Many NFTs were observed in PDC. Although the number of NFTs was small, many pretangles were seen in the neurons in CBD. Granular and hazy astrocytic inclusions were identified exclusively in PDC. Numerous argyrophilic neuropile threads were identified in CBD and PSP, but these were few in PDC. Many foamy spheroid bodies as well as coiled bodies were observed in PSP and CBD, but only a few were observed in PDC. In conclusion, PDC is a disease that is distinctly different from PSP and CBD. It is possible to differentiate between PSP and CBD by the occurrence of many pretangles in CBD, but some similarities between these 2 diseases indicate the existence of common pathological mechanisms.

Entities:  

Mesh:

Year:  2001        PMID: 11305875     DOI: 10.1093/jnen/60.4.393

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  11 in total

1.  Parkinson disease and incidental Lewy body disease: Just a question of time?

Authors:  Diego Iacono; Maria Geraci-Erck; Marcie L Rabin; Charles H Adler; Geidy Serrano; Thomas G Beach; Roger Kurlan
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

Review 2.  Progressive supranuclear palsy.

Authors:  K Tawana; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

3.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

4.  Sleepless Night and Day, the Plight of Progressive Supranuclear Palsy.

Authors:  Christine M Walsh; Leslie Ruoff; Kathleen Walker; Alaisa Emery; Jonathan Varbel; Elissaios Karageorgiou; Phi N Luong; Irida Mance; Hilary W Heuer; Adam L Boxer; Lea T Grinberg; Joel H Kramer; Bruce L Miller; Thomas C Neylan
Journal:  Sleep       Date:  2017-11-01       Impact factor: 5.849

5.  Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.

Authors:  Roberto Cilia; Carlo Rossi; Daniela Frosini; Duccio Volterrani; Chiara Siri; Cristina Pagni; Riccardo Benti; Gianni Pezzoli; Ubaldo Bonuccelli; Angelo Antonini; Roberto Ceravolo
Journal:  PLoS One       Date:  2011-05-02       Impact factor: 3.240

6.  Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.

Authors:  Helen Ling; H Ling; R de Silva; L A Massey; R Courtney; G Hondhamuni; N Bajaj; J Lowe; J L Holton; A Lees; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

7.  9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Authors:  L A Massey; M A Miranda; O Al-Helli; H G Parkes; J S Thornton; P-W So; M J White; L Mancini; C Strand; J Holton; A J Lees; T Revesz; T A Yousry
Journal:  Neuroimage Clin       Date:  2016-11-17       Impact factor: 4.881

Review 8.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 9.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

Review 10.  Alien limb syndrome: A Bayesian account of unwanted actions.

Authors:  Noham Wolpe; Frank H Hezemans; James B Rowe
Journal:  Cortex       Date:  2020-02-18       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.